Artificial intelligence (AI) is rapidly transforming various sectors, and clinical data management is no exception. While the potential applications of…
Read More
Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption
In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the pursuit of…
Read More
A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
This innovative CRISPR platform leverages a recently identified nuclease called Cas12a2, a protein capable of orchestrating RNA-triggered DNA shredding to…
Read More
Innovative targeted protein degradation strategy suppresses tumor growth
Researchers at Northwestern Medicine (IL, USA) have announced the successful development of novel synthetic biomolecular condensates capable of degrading intracellular…
Read More
Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic Interruption
In a significant advancement for reproductive medicine, researchers at Cornell University have successfully demonstrated a method for a safe, reversible,…
Read More
Revolution Medicines’ Daraxonrasib Achieves Landmark Survival Extension in Pancreatic Cancer, Heralding New Era of Targeted Therapy
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer. The 2026…
Read More
ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
Bistrifluron: A Promising New Chemical Offers Targeted Defense Against Destructive Drywood Termites
Researchers at the University of California, Riverside (UCR) have unveiled a groundbreaking discovery in the ongoing battle against drywood termites,…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
Datroway Receives FDA Approval for Metastatic Triple-Negative Breast Cancer, Marking a Significant Advancement in Targeted Therapy
The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…
Read MoreYOU MAY HAVE MISSED
